Displaying items by tag: Shionogi & Co Ltd
GRAND RAPIDS — Tetra Therapeutics Inc.’s sale to a Japanese pharmaceutical company provides a final pathway toward bringing to market potential new drugs to treat Alzheimer’s disease and a form of autism, as well as generates a handsome return for financial backers.
GRAND RAPIDS — Drug developer Tetra Therapeutics Inc. has reached a definitive merger agreement with Japan-based pharmaceutical company Shionogi & Co. Ltd. in a deal that could reach $500 million.
MiBiz Growth Report for March 15, 2020.
GRAND RAPIDS — Drug developer Tetra Therapeutics has secured a new equity investment from Japanese pharmaceutical company Shionogi & Co. Ltd.
GRAND RAPIDS — Tetra Therapeutics says it is enrolling patients faster than expected for a clinical trial on a potential new drug to treat Alzheimer’s disease.